WHO Chief Calls on Global Leaders to Boost HIV Prevention Efforts

(MENAFN) On Monday, the WHO Director-General urged global leaders to intensify their focus on HIV prevention and forge impactful partnerships aimed at eradicating AIDS.

Speaking at the International AIDS Society conference on HIV Science in Kigali, Rwanda, Tedros Adhanom Ghebreyesus emphasized the necessity for governments, scientists, civil society, and affected communities to unite in safeguarding the significant progress made in treatment, prevention, and care services.

“For over two decades, sustained investments have led to groundbreaking advances in treatment, prevention and care for millions of people. We cannot let that progress slip away,” he stressed.

Tedros condemned the recent abrupt cuts in funding for HIV programs, highlighting the severe disruptions these cause in providing access to lifesaving services across numerous countries.

The conference attracted more than 3,000 leaders, researchers, and civil society representatives worldwide to shape the next phase of the global HIV response.

During the event, WHO unveiled new guidelines endorsing the use of injectable lenacapavir (LEN) as an additional option for pre-exposure prophylaxis (PrEP), alongside injectable antiretroviral therapies for HIV treatment.

Health experts regard these updated recommendations as a pivotal policy development poised to transform the global fight against HIV.

However, Tedros cautioned that even the most effective medications have limited impact unless they reach those in need.

LEN, the world’s first twice-yearly injectable PrEP, provides a highly effective, long-acting alternative to daily oral pills and shorter-acting regimens, according to WHO.

With just two injections per year, LEN represents a major breakthrough in protecting vulnerable populations, especially those struggling with daily adherence, stigma, or healthcare access barriers.

“While an HIV vaccine remains elusive, lenacapavir is the next best thing: a long-acting antiretroviral shown in trials to prevent almost all HIV infections among those at risk,” Tedros remarked.

The UN agency reported stagnation in HIV prevention efforts, with 1.3 million new infections anticipated in 2024, disproportionately impacting key populations such as sex workers, men who have sex with men, transgender individuals, people who inject drugs, incarcerated persons, and young people.

“We have the tools to turn the corner on HIV,” Tedros declared, urging leaders to fulfill their pledges, back global HIV research, and resist the politicization of science and scientific institutions.

By the close of 2024, WHO data estimates approximately 40.8 million people worldwide will be living with HIV, with around 65% residing in the African region.

MENAFN15072025000045017169ID1109800955